List of COVID-19 vaccine authorizations

Last updated

National regulatory authorities have granted emergency use authorizations for twenty-four COVID-19 vaccines. Six of those have been approved for emergency or full use by at least one WHO-recognized stringent regulatory authority (Oxford–AstraZeneca, Pfizer–BioNTech, Sinopharm BIBP, Moderna, and Janssen). [1]

Contents

Overview maps

Oxford–AstraZeneca

  Full authorization
  Emergency authorization
  Eligible COVAX recipient
  Usage stopped

The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria [2] and Covishield, [3] is a viral vector vaccine [4] produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [4] [5] [6] Denmark and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder. [7] [8] [9] Slovakia suspended its use after the death of a predisposed recipient. [10] South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. [11] Japan approved the vaccine for emergency use in May 2021, but doesn't plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. [12] Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August. [13]

Full (2)
  1. Australia [14] [15]
  2. Brazil [16]
Emergency (173)
  1. Afghanistan [17] [18]
  2. Albania [19]
  3. Algeria [20]
  4. Andorra [21]
  5. Angola [22]
  6. Argentina [23]
  7. Armenia [24]
  8. Azerbaijan [25]
  9. Bahrain [26]
  10. Bangladesh [27] [28]
  11. Benin [25]
  12. Bhutan [29] [30]
  13. Bolivia [25]
  14. Bosnia and Herzegovina [31]
  15. Botswana [32]
  16. Brunei [33]
  17. Burkina Faso [34]
  18. Cambodia [25]
  19. Cameroon [25]
  20. Canada [35] [36]
  21. Cape Verde [37]
  22. Central African Republic [34]
  23. Chile [38]
  24. Colombia [39]
  25. Comoros [25]
  26. Congo, DR [40]
  27. Congo, Rep. of the [25]
  28. Costa Rica [41]
  29. Djibouti [25]
  30. Dominican Republic [42]
  31. East Timor [43]
  32. Ecuador [44]
  33. Egypt [45]
  34. El Salvador [46]
  35. Eswatini [47]
  36. Ethiopia [48] [49] [50]
  37. Fiji [25]
  38. Gambia [51]
  39. Georgia [52]
  40. Ghana [53]
  41. Guatemala [54]
  42. Guinea [34]
  43. Guinea-Bissau [55]
  44. Honduras [25]
  45. Hungary [56]
  46. India [57]
  47. Indonesia [58]
  48. Iran [59]
  49. Iraq [60]
  50. Ivory Coast [61]
  51. Japan [62]
  52. Jordan [63]
  53. Kenya [64]
  54. Kiribati [34]
  55. Kosovo [65] [66]
  56. Kuwait [67]
  57. Kyrgyzstan [34]
  58. Laos [34]
  59. Lebanon [68]
  60. Lesotho [69]
  61. Liberia [70]
  62. Libya [71] [72]
  63. Madagascar [25]
  64. Malawi [73] [74]
  65. Malaysia [75]
  66. Maldives [76]
  67. Mali [77]
  68. Mauritania [34]
  69. Mauritius [78]
  70. Mexico [79]
  71. Micronesia [34]
  72. Moldova [80]
  73. Mongolia [81]
  74. Montenegro [25]
  75. Morocco [82]
  76. Mozambique [25]
  77. Myanmar [83]
  78. Namibia [84]
  79. Nauru [85]
  80. Nepal [86]
  81. New Zealand [34]
  82. Nicaragua [25]
  83. Niger [25]
  84. Nigeria [87]
  85. North Macedonia [88]
  86. Oman [25]
  87. Pakistan [89]
  88. Palestine [25]
  89. Panama [25]
  90. Papua New Guinea [90] [91]
  91. Paraguay [34]
  92. Peru [92]
  93. Philippines [93]
  94. Qatar [34]
  95. Rwanda [94]
  96. Samoa [85]
  97. São Tomé and Príncipe [25]
  98. Saudi Arabia [95]
  99. Senegal [34]
  100. Serbia [96]
  101. Seychelles [97]
  102. Sierra Leone [98]
  103. Singapore [99] (restricted)
  104. Solomon Islands [25]
  105. Somalia [100]
  106. South Korea [101] [102]
  107. South Sudan [103]
  108. Sri Lanka [104]
  109. Sudan [105] [106]
  110. Syria [34]
  111. Tajikistan [107]
  112. Thailand [108]
  113. Togo [109]
  114. Tonga [110] [111] [112]
  115. Tunisia [34]
  116. Turkmenistan [34]
  117. Tuvalu [85]
  118. Uganda [113]
  119. Ukraine [114]
  120. United Arab Emirates [25]
  121. United Kingdom [115] [116] [117]
  122. Uruguay [25]
  123. Uzbekistan [25]
  124. Vanuatu [34]
  125. Vietnam [118]
  126. Yemen [119]
  127. Zambia [120] [121] [122]
  128. Zimbabwe [34]

EMA countries [2] [123]

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

CARPHA countries [124]

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname [125]
  14. Trinidad and Tobago


Non-country entities

Pfizer–BioNTech

  Full authorization
  Emergency authorization
  Eligible COVAX recipient

The Pfizer–BioNTech COVID-19 vaccine, also known as Comirnaty, [133] is an mRNA vaccine [134] produced by the German company BioNTech and the American company Pfizer. [134] [135] [136] In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma. [137] [138] [139] [140] [141] [142]

Full (10)
  1. Australia [143] [144]
  2. Brazil [145]
  3. Canada [146] [147] [148]
  4. Marshall Islands [lower-alpha 2] [lower-alpha 3]
  5. Micronesia [lower-alpha 2] [lower-alpha 3]
  6. New Zealand [149]
  7. Palau [lower-alpha 2] [lower-alpha 3]
  8. Saudi Arabia [152] [153]
  9. Switzerland [154] [155]
  10. United States [lower-alpha 3] [156] [157] [158]
Emergency (120)
  1. Afghanistan [25]
  2. Albania [159]
  3. Algeria [160]
  4. Andorra [161]
  5. Argentina [162]
  6. Armenia [163]
  7. Azerbaijan [34]
  8. Bahrain [164] [165]
  9. Bangladesh [166]
  10. Bhutan [34]
  11. Bolivia [25]
  12. Bosnia and Herzegovina [31]
  13. Botswana [167]
  14. Brunei [33]
  15. Cape Verde [25]
  16. Chile [168]
  17. Colombia [169]
  18. Costa Rica [170]
  19. Djibouti [34]
  20. Dominican Republic [171]
  21. Ecuador [172]
  22. Egypt [34]
  23. El Salvador [25] [173]
  24. Georgia [34]
  25. Guatemala [54]
  26. Guinea [34]
  27. Honduras [34]
  28. Indonesia [174]
  29. Iraq [175]
  30. Israel [176]
  31. Japan [62] [177] [178]
  32. Jordan [179]
  33. Kenya [180]
  34. Kosovo [34]
  35. Kuwait [181]
  36. Laos [34]
  37. Lebanon [182]
  38. Libya [25]
  39. Malawi [183]
  40. Malaysia [184]
  41. Maldives [185]
  42. Mexico [186] [187]
  43. Moldova [80]
  44. Monaco [188]
  45. Mongolia [189]
  46. Montenegro [34]
  47. Morocco [34]
  48. Nigeria [190]
  49. North Macedonia [191]
  50. Oman [192]
  51. Pakistan [193]
  52. Palestine [25]
  53. Panama [194]
  54. Papua New Guinea [195]
  55. Paraguay [196] [197]
  56. Peru [198]
  57. Philippines [199]
  58. Qatar [200]
  59. Rwanda [25]
  60. San Marino [25]
  61. Serbia [201] [202]
  62. Singapore [203]
  63. South Africa [204] [205]
  64. South Korea [206] [207]
  65. Sri Lanka [208]
  66. Sudan [25]
  67. Thailand [209]
  68. Tunisia [153]
  69. Turkey [210]
  70. Ukraine [211]
  71. United Arab Emirates [212]
  72. United Kingdom [213] [214] [215]
  73. Uruguay [216]
  74. Uzbekistan [217]
  75. Vatican City [218] [219]
  76. Vietnam [220]

EMA countries [133] [123]

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

CARPHA countries [221] [222]

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago


Non-country entities

Moderna

  Full authorization
  Emergency authorization
  Eligible COVAX recipient

The Moderna COVID-19 vaccine, also known as Spikevax, [229] is an mRNA vaccine [230] produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations. [231] [232]

Full (4)
  1. Australia [233]
  2. Canada [234] [36] [148]
  3. Switzerland [235]
  4. United Kingdom [236] [237]
Emergency (97)
  1. Andorra [21]
  2. Argentina [238]
  3. Armenia [34]
  4. Bahrain [34]
  5. Bangladesh [239]
  6. Bhutan [34]
  7. Botswana [240]
  8. Brazil [241]
  9. Brunei [34]
  10. Colombia [242]
  11. Congo, Rep. of the [25]
  12. El Salvador [34]
  13. Fiji [34]
  14. Ghana [243]
  15. Guatemala [54]
  16. Honduras [244]
  17. India [245]
  18. Indonesia [246]
  19. Israel [247]
  20. Japan [62] [248]
  21. Jordan [34]
  22. Kenya [249]
  23. Kuwait [250]
  24. Libya [25]
  25. Malaysia [251]
  26. Maldives [252]
  27. Marshall Islands [lower-alpha 2]
  28. Malawi [253]
  29. Mexico [254] [255]
  30. Micronesia [lower-alpha 2]
  31. Moldova [256]
  32. Mongolia [81]
  33. Nigeria [257]
  34. Pakistan [34]
  35. Palau [lower-alpha 2]
  36. Palestine [25]
  37. Paraguay [34]
  38. Peru [258]
  39. Philippines [259]
  40. Qatar [260]
  41. Rwanda [25]
  42. Saudi Arabia [95]
  43. Singapore [261]
  44. South Korea [262]
  45. Sri Lanka [34]
  46. Tajikistan [263]
  47. Thailand [264]
  48. Tunisia [34]
  49. Ukraine [265]
  50. United Arab Emirates [266]
  51. United States [267] [268]
  52. Uzbekistan [269]
  53. Vietnam [270] [271]

EMA countries [229] [123]

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

CARPHA countries [221] [272]

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines
  13. Suriname
  14. Trinidad and Tobago


Non-country entities

Janssen

  Full authorization
  Full authorization, not used
  Emergency authorization
  Eligible COVAX recipient
  Usage stopped

The Janssen COVID-19 vaccine [276] is a viral vector vaccine [277] produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center. [278] [279] It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen. [280] Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. [281] Canada never started deploying the Janssen Vaccine after issues with doses sent from the Emergent BioSolutions Manufacturing Plant. After 300,000 doses were rejected, no Canadian Province has requested the Janssen Vaccine. [282]

Full (2)
  1. Australia (not used) [283] [284]
  2. Switzerland [285] [286]
Emergency (105)
  1. Afghanistan [34]
  2. Argentina [287]
  3. Andorra [21]
  4. Bahamas [288]
  5. Bahrain [289] [290]
  6. Bangladesh [291] [292]
  7. Bolivia [34]
  8. Botswana [293]
  9. Brazil [294]
  10. Brunei [34]
  11. Cambodia [34]
  12. Canada [295]
  13. Chile [296]
  14. Colombia [297]
  15. Djibouti [34]
  16. Egypt [34]
  17. Ghana [298]
  18. Guinea [34]
  19. Honduras [25]
  20. India [299]
  21. Indonesia [300]
  22. Iran [34]
  23. Jordan [34]
  24. Kenya [301]
  25. Kuwait [302]
  26. Laos [34]
  27. Libya [25]
  28. Malaysia [303]
  29. Maldives [304]
  30. Marshall Islands [lower-alpha 2]
  31. Mexico [305] [306]
  32. Micronesia [lower-alpha 2]
  33. Moldova [256]
  34. Morocco [34]
  35. Nepal [307]
  36. New Zealand [34]
  37. Nigeria [308]
  38. Palau [lower-alpha 2]
  39. Palestine [34]
  40. Papua New Guinea [34]
  41. Peru [309]
  42. Philippines [310]
  43. Qatar [34]
  44. Saudi Arabia [34]
  45. Singapore [99] (restricted)
  46. Somalia [34]
  47. South Africa [311]
  48. South Korea [312]
  49. Sudan [34]
  50. Syria [34]
  51. Tanzania [34]
  52. Thailand [313]
  53. Tunisia [314]
  54. Ukraine [34]
  55. United Kingdom [315]
  56. United States [316] [317]
  57. Vietnam [318] [319]
  58. Yemen [34]
  59. Zambia [120] [121] [122]
  60. Zimbabwe [320]

EMA countries [123]

  1. Austria
  2. Belgium
  3. Bulgaria
  4. Croatia
  5. Cyprus
  6. Czech Republic
  7. Denmark
  8. Estonia
  9. Finland
  10. France
  11. Germany
  12. Greece
  13. Hungary
  14. Iceland
  15. Ireland
  16. Italy
  17. Latvia
  18. Liechtenstein
  19. Lithuania
  20. Luxembourg
  21. Malta
  22. Netherlands
  23. Norway
  24. Poland
  25. Portugal
  26. Romania
  27. Slovakia
  28. Slovenia
  29. Spain
  30. Sweden

CARPHA countries [272]

  1. Antigua and Barbuda
  2. Bahamas
  3. Barbados
  4. Belize
  5. Dominica
  6. Grenada
  7. Guyana
  8. Haiti
  9. Jamaica
  10. Saint Kitts and Nevis
  11. Saint Lucia
  12. Saint Vincent and the Grenadines [321]
  13. Suriname
  14. Trinidad and Tobago


Non-country entities

Sinopharm-BBIBP

  Full authorization
  Emergency authorization
  Eligible COVAX recipient

The Sinopharm BIBP COVID-19 vaccine,is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Beijing Institute of Biological Products. [326] [327]

Full (4)
  1. Bahrain [328]
  2. China [329]
  3. Seychelles [330]
  4. United Arab Emirates [331] [332]
Emergency (93)
  1. Afghanistan [333]
  2. Algeria [334]
  3. Angola [335]
  4. Antigua and Barbuda [336]
  5. Argentina [337]
  6. Armenia [34]
  7. Bangladesh [338]
  8. Barbados [339]
  9. Belarus [340]
  10. Belize [25]
  11. Bhutan [341]
  12. Bolivia [342]
  13. Bosnia and Hergezovina [343]
  14. Brazil [241]
  15. Brunei [344]
  16. Cambodia [345]
  17. Cameroon [25]
  18. Chad [346]
  19. Comoros [25]
  20. Congo [25]
  21. Cuba [347]
  22. Djibouti [25]
  23. Dominica [348]
  24. Dominican Republic [349]
  25. Egypt [350]
  26. Equatorial Guinea [351]
  27. Ethiopia [352]
  28. Gabon [353]
  29. Gambia [34]
  30. Georgia [354]
  31. Guinea [34]
  32. Guinea-Bissau [25]
  33. Guyana [355]
  34. Hungary [356] [357]
  35. Indonesia [358]
  36. Iran [359]
  37. Iraq [60]
  38. Ivory Coast [34]
  39. Jordan [360]
  40. Kazakhstan [361]
  41. Kenya [249]
  42. Kuwait [34]
  43. Kyrgyzstan [362]
  44. Laos [363]
  45. Lebanon [364]
  46. Libya [365]
  47. Malaysia [366]
  48. Malawi [367]
  49. Maldives [368]
  50. Mauritania [369]
  51. Mauritius [25]
  52. Mexico [370] [371]
  53. Moldova [372]
  54. Mongolia [373]
  55. Montenegro [374]
  56. Morocco [375]
  57. Mozambique [376]
  58. Myanmar [377]
  59. Namibia [378]
  60. Nepal [379]
  61. Niger [380]
  62. Nigeria [381]
  63. North Korea [382]
  64. North Macedonia [383]
  65. Pakistan [384]
  66. Palestine [385]
  67. Papua New Guinea [386]
  68. Paraguay [34]
  69. Peru [387]
  70. Philippines [388]
  71. Qatar [389]
  72. Rwanda [390]
  73. Saudi Arabia [391]
  74. Senegal [392]
  75. Serbia [393]
  76. Sierra Leone [394]
  77. Singapore [395] (restricted)
  78. Solomon Islands [396]
  79. Somalia [397]
  80. South Sudan [398]
  81. Sri Lanka [399]
  82. Sudan [400] [401]
  83. Suriname [34]
  84. Syria [34]
  85. Thailand [402]
  86. Trinidad and Tobago [403]
  87. Tunisia [404]
  88. Turkmenistan [405]
  89. Vanuatu [406]
  90. Venezuela [407]
  91. Vietnam [408]
  92. Zambia [409]
  93. Zimbabwe [410]


Non-country entities

Sputnik V

  Full authorization
  Emergency authorization
  Eligible COVAX recipient (ongoing assessment) [128]
   European Medicines Agency (EMA) review in progress [414]

The Sputnik V COVID-19 vaccine is a viral vector vaccine [415] produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.

Full (2)
  1. Turkmenistan [416] [417]
  2. Uzbekistan [418]
Emergency (75)
  1. Albania [19]
  2. Algeria [419]
  3. Angola [420]
  4. Antigua and Barbuda [421]
  5. Argentina [422]
  6. Armenia [423]
  7. Azerbaijan [424] [425]
  8. Bahrain [426]
  9. Bangladesh [427]
  10. Belarus [428]
  11. Bolivia [429]
  12. Bosnia and Herzegovina [430]
  13. Brazil [431] (restricted)
  14. Cameroon [432]
  15. Chile [433]
  16. Congo [420]
  17. Djibouti [420]
  18. Ecuador [434]
  19. Egypt [45]
  20. Gabon [435]
  21. Gambia [436]
  22. Ghana [437]
  23. Guatemala [438]
  24. Guinea [439]
  25. Guyana [440]
  26. Honduras [441]
  27. Hungary [442] [430] [357]
  28. India [443]
  29. Indonesia [444]
  30. Iran [445]
  31. Iraq [446]
  32. Ivory Coast [34]
  33. Jordan [447]
  34. Kazakhstan [448]
  35. Kenya [449]
  36. Kyrgyzstan [450]
  37. Laos [363]
  38. Lebanon [451]
  39. Libya [71] [72]
  40. Maldives [452]
  41. Mali [453]
  42. Mauritius [454]
  43. Mexico [455]
  44. Moldova [80]
  45. Mongolia [456]
  46. Montenegro [457]
  47. Morocco [458]
  48. Myanmar [459]
  49. Namibia [460]
  50. Nepal [461]
  51. Nicaragua [462]
  52. Nigeria [463]
  53. North Macedonia [464]
  54. Oman [465]
  55. Pakistan [466]
  56. Palestine [467]
  57. Panama [468]
  58. Paraguay [469]
  59. Peru [470]
  60. Philippines [471]
  61. Russia [472]
  62. Saint Vincent and the Grenadines [321]
  63. San Marino [473] [474]
  64. Serbia [475]
  65. Seychelles [476]
  66. Slovakia [34]
  67. Sri Lanka [477]
  68. Syria [478]
  69. Thailand [479]
  70. Tunisia [480]
  71. Turkey [481]
  72. United Arab Emirates [482]
  73. Venezuela [483]
  74. Vietnam [484]
  75. Zimbabwe [485]


Non-country entities

Rejected

  1. South Africa. [488]

CoronaVac

  Full authorization
  Emergency authorization
  Eligible COVAX recipient
   European Medicines Agency (EMA) review in progress [489]
  Usage stopped

CoronaVac is an inactivated virus vaccine [490] produced by the Chinese company Sinovac Biotech. [490] [491] [492]

Full (1)
  1. China [493]
Emergency (64)
  1. Albania [19]
  2. Armenia [494]
  3. Azerbaijan [495]
  4. Bangladesh [496]
  5. Benin [497]
  6. Bolivia [498]
  7. Bosnia and Herzegovina [499]
  8. Botswana [500]
  9. Brazil [501]
  10. Cambodia [502]
  11. Chile [503]
  12. Colombia [504]
  13. Djibouti [505]
  14. Dominica [153]
  15. Dominican Republic [506]
  16. East Timor [507]
  17. Ecuador [508]
  18. Egypt [509]
  19. El Salvador [510]
  20. Equatorial Guinea [34]
  21. Fiji [511]
  22. Gabon [153]
  23. Georgia [512]
  24. Guinea [513]
  25. Guyana [153]
  26. Hungary [34]
  27. Indonesia [514] [515]
  28. Kazakhstan [516]
  29. Laos [493]
  30. Libya [517]
  31. Malawi [367]
  32. Maldives [34]
  33. Mexico [518]
  34. Moldova [519]
  35. Morocco [153]
  36. Myanmar [520]
  37. Nepal [521]
  38. North Macedonia [522]
  39. Oman [465]
  40. Pakistan [523]
  41. Palestine [34]
  42. Panama [524]
  43. Paraguay [525]
  44. Philippines [526]
  45. Saint Vincent and the Grenadines [153]
  46. Saudi Arabia [391]
  47. Singapore [527]
  48. Somalia [25]
  49. South Africa [528]
  50. Sri Lanka [529]
  51. Sudan [25]
  52. Syria [34]
  53. Tajikistan [530]
  54. Tanzania [531]
  55. Thailand [532]
  56. Togo [533]
  57. Tunisia [534]
  58. Turkey [535]
  59. Turkmenistan [536]
  60. Ukraine [537]
  61. Uruguay [493]
  62. Uzbekistan [538]
  63. Venezuela [539]
  64. Zimbabwe [485]


Non-country entities

Covaxin

  Full authorization
  Emergency authorization
  Eligible COVAX recipient (ongoing assessment) [544] [545]
  Suspended import

Covaxin is an inactivated virus vaccine produced by the Indian company Bharat Biotech and the Indian Council of Medical Research. [57]

Full (0)
Emergency (21)
  1. Botswana [546]
  2. Brazil (restricted) [431]
  3. Central African Republic [25]
  4. Comoros [25]
  5. Ethiopia [34]
  6. Guatemala [546]
  7. Guyana [546]
  8. India [57]
  9. Iran [547]
  10. Mauritius [548]
  11. Mexico [549]
  12. Myanmar [550]
  13. Nepal [551]
  14. Nicaragua [546]
  15. Pakistan [34]
  16. Paraguay [552] [553]
  17. Philippines [554] [555]
  18. Sri Lanka [556]
  19. Venezuela [546]
  20. Zimbabwe [557]

Sputnik Light

  Full authorization
  Emergency authorization

Sputnik Light is a viral vector vaccine, [558] produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It actually consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector. [559]

Full (0)
Emergency (16)
  1. Angola [560]
  2. Bahrain [561]
  3. Belarus [562]
  4. Congo [563]
  5. Egypt [564]
  6. Kazakhstan [565]
  7. Kyrgyzstan [566]
  8. Mauritius [567]
  9. Mongolia [568]
  10. Nicaragua [569]
  11. Palestine [570]
  12. Philippines [571]
  13. Russia [572]
  14. Syria [573]
  15. United Arab Emirates [574]
  16. Venezuela [575]


Convidecia

  Full authorization
  Emergency authorization
  Eligible COVAX recipient (ongoing assessment) [128]

Convidecia is a viral vector vaccine [576] produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.

Full (1)
  1. China [577]
Emergency (9)
  1. Argentina [578]
  2. Chile [579]
  3. Ecuador [580]
  4. Hungary [581] [357]
  5. Indonesia [300]
  6. Malaysia [582]
  7. Mexico [518]
  8. Moldova [256]
  9. Pakistan [583]

Sinopharm-WIBP

  Full authorization
  Emergency authorization

The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.

Full (1)
  1. China [584]
Emergency (5)
  1. North Macedonia [34]
  2. Peru [34]
  3. Philippines [585]
  4. United Arab Emirates [153]
  5. Venezuela [34]

Abdala

  Full authorization
  Emergency authorization

Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.

Full (0)
Emergency (4)
  1. Cuba [586] [587] [588]
  2. Nicaragua [589]
  3. Venezuela [590]
  4. Vietnam [591]

EpiVacCorona

  Full authorization
  Emergency authorization

EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR . [592]

Full (1)
  1. Turkmenistan [593] [594]
Emergency (2)
  1. Belarus [595]
  2. Russia [596] [597]

Zifivax

  Full authorization
  Emergency authorization

Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical. [598]

Full (0)
Emergency (3)
  1. China [599]
  2. Indonesia [600]
  3. Uzbekistan [601]

Soberana 02

  Full authorization
  Emergency authorization

Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba. [602] [lower-alpha 4]

Full (0)
Emergency (3)
  1. Cuba [603]
  2. Iran [602]
  3. Nicaragua [604]

QazCovid-in

  Full authorization
  Emergency authorization

QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. [605]

Full (0)
Emergency (2)
  1. Kazakhstan [605]
  2. Kyrgyzstan [606] [607] [608]

CoviVac

  Full authorization
  Emergency authorization

CoviVac is an inactivated virus vaccine [558] produced by the Chumakov Centre at the Russian Academy of Sciences. [609]

Full (0)
Emergency (1)
  1. Russia [610]

Minhai

Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China. [611]

Full (0)
Emergency (1)
  1. China [611]

COVIran Barekat

COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran. [612]

Full (0)
Emergency (1)
  1. Iran [612]

FAKHRAVAC

FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense. [613] The vaccine was abandoned due to a lack of demand as imports grow. [614]

Full (0)
Emergency (1)
  1. Iran [613]

Chinese Academy of Medical Sciences

Chinese Academy of Medical Sciences COVID-19 vaccine, is an inactivated virus vaccine developed by Chinese Academy of Medical Sciences. [615]

Full (0)
Emergency (1)
  1. China [615]

Medigen

MVC-COV1901, is a protein subunit vaccine developed by Medigen Vaccine Biologics and Dynavax Technologies. [616]

Full (0)
Emergency (1)
  1. Taiwan [616]

ZyCoV-D

ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian-based pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council. [617]

Full (0)
Emergency (1)
  1. India [617]

COVAX-19

COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen. [618]

Full (0)
Emergency (1)
  1. Iran [618]


Notes

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 via CARPHA authorization [124]
  2. 1 2 3 4 5 6 7 8 9 via United States authorization through Compact of Free Association [150] [151]
  3. 1 2 3 4 Full approval only for those aged 16+. EUA still applies for recipients aged 12-15.
  4. While there has been a mass innoculation campaign in Cuba under an "observational study", [586] no formal emergency authorisation has been given as of 9 July 2021.

Related Research Articles

BioNTech German biotechnology company

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger ribonucleic acid (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer.

Vaccine diplomacy Use of vaccines

Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). It is one of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well logistics, country readiness and in-country delivery.

Sinopharm BIBP COVID-19 vaccine Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

History of COVID-19 vaccine development Scientific work to develop a vaccine for COVID-19

COVID-19's caused virus, SARS-CoV-2, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development shows North American entities to have about 40% of the activity, compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.

COVID-19 vaccination in Albania

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

COVID-19 vaccination in Peru

The COVID-19 vaccination program in Peru is the national vaccination strategy to protect the population against SARS-CoV-2 employing vaccines developed for the COVID-19 pandemic in Peru. Vaccination began on 9 February 2021, after three days of arrival of first vaccines. On a nation message, the head of state Francisco Sagasti confirmed the purchase of 38 millions of vaccines, being one million of vaccines for health personnel.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. Sinopharm COVID-19 vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in South Korea Plan to immunize against COVID-19

COVID-19 vaccination in South Korea is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Indonesia

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks sixth in the world and third in Asia.

The COVID-19 vaccination program in Argentina is an ongoing effort of mass immunization. Vaccination against COVID-19 began in Argentina on 29 December 2020 aiming at health professionals. Argentina struck a deal with the United Kingdom in November 2020 for a British made vaccine produced by the pharmaceutical company AstraZeneca and the University of Oxford. The vaccines are part of a deal where Argentina received 22.4 million doses. During the first week, 39,599 doses were applied to health professionals.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, Sinopharm's BBIBP-CorV accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna COVID-19 vaccine through COVAX.

COVID-19 vaccination in Taiwan Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 70% of the population by late October 2021.

References

  1. "Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process" (PDF).
  2. 1 2 "Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR". European Medicines Agency (EMA).
  3. "Covishield and Covaxin: What we know about India's Covid-19 vaccines". BBC News. 4 March 2021. Archived from the original on 7 March 2021. Retrieved 8 March 2021.
  4. 1 2 "Investigating a Vaccine Against COVID-19". ClinicalTrials.gov . United States National Library of Medicine. 26 May 2020. NCT04400838. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
  5. "A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register. European Union. 21 April 2020. EudraCT 2020-001228-32. Archived from the original on 5 October 2020. Retrieved 3 August 2020.
  6. O'Reilly P (26 May 2020). "A Phase III study to investigate a vaccine against COVID-19". ISRCTN. doi: 10.1186/ISRCTN89951424 . ISRCTN89951424.
  7. "Denmark continues its vaccine rollout without the COVID-19 vaccine from AstraZeneca". Danish Health Authority. 14 April 2021. Retrieved 31 July 2021. That is why it is important to emphasise that it is still an approved vaccine.
  8. Peltier, Elian (14 April 2021). "Denmark says it's permanently stopping use of the AstraZeneca vaccine". The New York Times.
  9. omsorgsdepartementet, Helse-og (12 May 2021). "AstraZeneca-vaksinen tas ut av koronavaksinasjons-programmet". Regjeringen.no (in Norwegian). Retrieved 12 May 2021.
  10. "Slovakia suspends use of AstraZeneca COVID-19 vaccine as a recipient dies". Reuters. Prague. 11 May 2021. Retrieved 23 June 2021.
  11. "South Africa sells AstraZeneca COVID-19 vaccines to other African countries". Reuters. Johannesburg. 21 March 2021. Retrieved 23 June 2021.
  12. "Japan to donate millions more AstraZeneca vaccine doses across Asia". Kyodo News. 2021-06-25.
  13. "Japan to give COVID-19 emergency areas AstraZeneca vaccine". The Japan Times. 2021-08-04. Retrieved 2021-08-28.
  14. "AstraZeneca coronavirus vaccine approved for use in Australia by TGA". ABC News (Australia). 16 February 2021. Retrieved 16 February 2021.
  15. "TGA provisionally approves AstraZeneca's COVID-19 vaccine". Therapeutic Goods Administration (TGA). 16 February 2021. Retrieved 16 February 2021.
  16. "Brazil grants full approval to Oxford vaccine, orders Sputnik". Brasilia: France 24. Agence France-Presse. 12 March 2021. Retrieved 13 March 2021.
  17. Sediqi, Abdul Qadir (7 February 2021). "First doses of COVID-19 vaccine arrive in Afghanistan from India". Reuters. Retrieved 24 February 2021.
  18. "India donates 500,000 COVID vaccines to Afghanistan". Al Jazeera. Retrieved 24 February 2021.
  19. 1 2 3 Semini, Llazar. "Albania starts mass COVID vaccinations before tourist season". ABC News. Retrieved 29 March 2021.
  20. Kreo. "البلاد الوطني / وزارة الصناعات الصيدلانية ترخص باستعمال لقاح "أسترا زينيكا -أوكسفورد " المضاد لكورونا". elbilad.net (in Arabic). Retrieved 1 April 2021.
  21. 1 2 3 "Informació en relació amb la vacunació contra la COVID-19" (PDF) (in Catalan). Govern d'Andorra. Retrieved 14 March 2021.
  22. AfricaNews (3 March 2021). "Angola begins Covid immunization fight with COVAX vaccines". Africanews. Event occurs at CET13:13:37+01:00. Retrieved 14 April 2021.
  23. "Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine". Reuters. 30 December 2020. Retrieved 30 December 2020.
  24. "Armenia Scraps Restrictions For AstraZeneca Vaccine". «Ազատ Եվրոպա/Ազատություն» ռադիոկայան (in Armenian).
  25. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 "COVID Data Tracker". U.S. Centers for Disease Control and Prevention (CDC). 28 March 2020.
  26. "Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India". Saudigazette. 25 January 2021. Retrieved 30 January 2021.
  27. "Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use". The Daily Star . 4 January 2021. Retrieved 6 January 2021.
  28. "Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine". aa.com.tr. Retrieved 6 January 2021.
  29. "Bhutan receives 400,000 doses of COVID-19 vaccine from India". Xinhuanet. Retrieved 1 April 2021.
  30. "Bhutan begins biggest vaccination drive against COVID-19". CNA. Retrieved 1 April 2021.
  31. 1 2 "Pfizer/BioNTech COVID-19 vaccines shipped by COVAX arrive in Bosnia and Herzegovina". United Nations. Retrieved 14 April 2021.
  32. "Botswana starts COVID-19 vaccine rollout". Xinhuanet. Retrieved 1 April 2021.
  33. 1 2 "COVID-19: Brunei to begin mass vaccination on April 3". TheScoop. 2 April 2021. Retrieved 6 April 2021.
  34. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 "WHO Coronavirus (COVID-19) Dashboard". World Health Organization (WHO).
  35. "Regulatory Decision Summary – AstraZeneca COVID-19 Vaccine". Health Canada . 26 February 2021. Retrieved 26 February 2021.
  36. 1 2 "Drug and vaccine authorizations for COVID-19: List of applications received". Health Canada, Government of Canada. 9 December 2020. Retrieved 9 December 2020.
  37. "COVID-19 vaccines sent by COVAX arrive in Cabo Verde". ReliefWeb. Retrieved 17 April 2021.
  38. "Instituto de Salud Pública de Chile" (in Spanish). Retrieved 1 April 2021.
  39. "Colombia approves emergency use of AstraZeneca coronavirus vaccine". Bogotá: Reuters. 23 February 2021. Retrieved 22 March 2021.
  40. "More than 1.7 million COVID-19 vaccines arrive in the Democratic Republic of Congo". www.unicef.org. Retrieved 25 April 2021.
  41. "Costa Rica approves use of AstraZeneca's COVID-19 vaccine". Q COSTA RICA. 9 April 2021.
  42. "La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19". Agencia EFE (in Spanish). 31 December 2020.
  43. "First vaccines for East Timor arrive in Dili on Monday – LUSA". COVID-19 Timor-Leste Dashboard. April 1, 2021. Archived from the original on April 2, 2021.
  44. "Ecuador approves use of AstraZeneca vaccine for COVID-19". Reuters. 24 January 2021. Retrieved 30 January 2021.
  45. 1 2 "COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs". Gulf News. Retrieved 24 February 2021.
  46. "El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine". Reuters. 30 December 2020.
  47. "Eswatini launches nationwide COVID-19 vaccination campaign". World Health Organization (WHO). Retrieved 1 April 2021.
  48. "Ethiopia begins COVID-19 vaccine rollout". aa.com.tr. Retrieved 19 March 2021.
  49. "Ethiopia introduces COVID-19 vaccine in a national launching ceremony". World Health Organization (WHO). Retrieved 19 March 2021.
  50. "Ethiopia says it has secured 9 million doses of COVID-19 vaccines till April". Reuters. 9 February 2021. Retrieved 19 March 2021.
  51. "The Arrival of COVAX vaccines Raises Hope in The Gambia". World Health Organization (WHO). Retrieved 19 March 2021.
  52. "Georgia to receive first doses of COVID-19 vaccine in early March instead of February". Agenda.ge. Retrieved 22 March 2021.
  53. "Welcome to Ghana Food And Drug Authority". fdaghana.gov.gh. Retrieved 1 April 2021.
  54. 1 2 3 "COVID-19 Information". U.S. Embassy in Guatemala. 25 February 2020.
  55. "Today, 28,800 doses of COVID-19 vaccine arrive in Bissau". www.unicef.org.
  56. "Hungary approves two more vaccines not authorised by EU regulator". euronews. 22 March 2021. Retrieved 1 April 2021.
  57. 1 2 3 Schmall E, Yasir S (3 January 2021). "India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other". The New York Times. Retrieved 3 January 2021.
  58. "BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca". Kompas.com. Retrieved 10 February 2021.
  59. "Iran issues permit for emergency use for three other COVID-19 vaccines: Official". IRNA English. 17 February 2021. Retrieved 1 April 2021.
  60. 1 2 "Iraq approves Sinopharm, AstraZeneca vaccines". Big News Network.com. Retrieved 30 January 2021.
  61. "Covax: Ivory Coast and Ghana begin mass Covid vaccination rollouts". BBC News. 1 March 2021. Retrieved 19 March 2021.
  62. 1 2 3 "Japan Approves Moderna, AstraZeneca Coronavirus Vaccines". Bloomberg. 20 May 2021. Retrieved 2 July 2021.
  63. "COVAX roll-out - Jordan". www.gavi.org. Retrieved 14 May 2021.
  64. "Kenya Receives 1M Vaccine Doses, Will Distribute to Health Workers First". Voice of America. Retrieved 19 March 2021.
  65. "Kosovo receives first COVID-19 vaccines through Covax scheme". euronews. 29 March 2021. Retrieved 14 April 2021.
  66. "Kosovo PM Becomes Nation's First Person To Receive COVID-19 Vaccine". RadioFreeEurope/RadioLiberty. Retrieved 14 April 2021.
  67. Godinho, Varun (31 January 2021). "Kuwait authorises emergency use of Oxford-AstraZeneca Covid-19 vaccine". Gulf Business. Retrieved 1 April 2021.
  68. "Lebanon Received 33600 Doses of The AstraZeneca Vaccine as First Batch". Ministry of Public Health of Lebanon.
  69. "Lesotho receives 1st batch of COVID-19 vaccines". aa.com.tr. Retrieved 19 March 2021.
  70. "96,000 Doses of COVID-19 Vaccine Arrives in Liberia". World Health Organization (WHO). Retrieved 11 April 2021.
  71. 1 2 "Libya kicks off delayed COVID-19 vaccination drive". Al Jazeera. Retrieved 25 April 2021.
  72. 1 2 "57,600 COVID-19 vaccine doses received today in Tripoli, Libya". ReliefWeb. Retrieved 25 April 2021.
  73. "Malawi to receive COVID-19 vaccines in late February – Xinhua". Xinhuanet. Retrieved 19 March 2021.
  74. "Malawi Sticks to AstraZeneca Despite Concerns Over Efficacy". Voice of America. Retrieved 19 March 2021.
  75. Sipalan, Joseph; Donovan, Kirsten (3 March 2021). "Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use". Reuters. Retrieved 7 March 2021.
  76. "Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua". Xinhuanet. Retrieved 19 February 2021.
  77. AfricaNews (6 March 2021). "Mali receives first batch of COVID-19 vaccines". Africanews. Retrieved 1 April 2021.
  78. AfricaNews (26 January 2021). "Mauritius begins vaccinating frontline health workers against covid-19". Africanews. Retrieved 24 February 2021.
  79. "Mexico approves AstraZeneca COVID-19 vaccine, minister says". Reuters. 5 January 2021. Retrieved 14 January 2021.
  80. 1 2 3 Foundation, Thomson Reuters. "Moldova approves Russia's Sputnik V vaccine as political row simmers". news.trust.org. Retrieved 1 April 2021.
  81. 1 2 "Mongolia approved three Covid-19 vaccines". News.MN. 11 January 2021. Retrieved 1 April 2021.
  82. "Morocco approves AstraZeneca/Oxford COVID-19 vaccine – Minister". Reuters. 7 January 2021. Retrieved 22 March 2021.
  83. "Myanmar launches nationwide COVID-19 vaccination program". Xinhua News. 27 January 2021.
  84. "Importation of COVID-19 Vaccines into Namibia for Public Use and Guidance on Administration of Vaccines by Private Health Care Providers". Republic of Namibia Ministry of Health and Social Services. Public Notice No.: 05/032021. 2021-03-31.CS1 maint: others (link)
  85. 1 2 3 "Samoa receives 24,000 doses of COVID-19 vaccines through the COVAX facility - Samoa". ReliefWeb. Retrieved 7 June 2021.
  86. "Nepal approves AstraZeneca COVID vaccine for emergency use – government statement". Reuters. 15 January 2021.
  87. "Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria". BBC News Pidgin. Retrieved 24 February 2021.
  88. "Сѐ за вакцините". Официјална веб-страница за вакцинација против КОВИД19 (in Macedonian).
  89. "Pakistan approves AstraZeneca COVID-19 vaccine for emergency use". 16 January 2021.
  90. "PNG prime minister first to be vaccinated with Australian-supplied doses 'to show it's safe'". The Guardian. 30 March 2021. Retrieved 1 April 2021.
  91. "Australia gives Covid-19 vaccine doses to hard-hit Papua New Guinea". France 24. 17 March 2021. Retrieved 1 April 2021.
  92. "DIGEMID". www.digemid.minsa.gob.pe (in Spanish).
  93. "Philippine regulator approves emergency use of AstraZeneca vaccine". Reuters. 28 January 2021. Retrieved 28 January 2021.
  94. "Rwanda receives COVID-19 Vaccines through COVAX". World Health Organization (WHO). Retrieved 19 March 2021.
  95. 1 2 "AstraZeneca and Moderna vaccines to be administered in Saudi Arabia". Gulf News. Retrieved 19 January 2021.
  96. "Serbia receives first shipment of AstraZeneca COVID-19 vaccine". Reuters. 21 February 2021. Retrieved 19 March 2021.
  97. Bhattacherjee, Kallol (22 January 2021). "Coronavirus | Myanmar, Mauritius, Seychelles receive Covishield vaccine". The Hindu. Retrieved 1 April 2021.
  98. "COVID-19 vaccines shipped by COVAX arrive in Sierra Leone". World Health Organization (WHO). Retrieved 19 March 2021.
  99. 1 2 "Those who opt for Sinovac, other vaccines under WHO emergency list to be considered fully vaccinated". CNA. 6 August 2021. Retrieved 6 August 2021.
  100. "Somalia Receives Its First Batch of COVID-19 Vaccines". Voice of America. Retrieved 1 April 2021.
  101. Kim, Han-joo (10 February 2021). "S. Korea approves AstraZeneca's COVID-19 vaccine for all adults". Yonhap News. Retrieved 10 February 2021.
  102. Maresca, Thomas (10 February 2021). "South Korea approves AstraZeneca COVID-19 vaccine". United Press International. Retrieved 10 February 2021.
  103. "COVID-19 vaccination kicks-off in South Sudan". World Health Organization (WHO). Retrieved 14 April 2021.
  104. "Sri Lanka approves vaccine amid warnings of virus spread". Associated Press. 22 January 2021. Retrieved 22 January 2021.
  105. "COVID-19 vaccination in Sudan". UNICEF . Retrieved 19 March 2021.
  106. "Sudan receives first delivery of COVID-19 vaccines with over 800,000 doses". UNICEF . Retrieved 19 March 2021.
  107. "Tajikistan becomes first country in Central Asia to receive COVID-19 vaccine through COVAX Facility". unicef.org. Retrieved 14 April 2021.
  108. "Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca". Pattaya Mail. 23 January 2021.
  109. First, Togo. "Covid-19: First vaccination campaign to soon begin". togofirst.com. Retrieved 19 March 2021.
  110. "Over 500 people given first COVID-19 vaccine shot in Tonga – Xinhua". www.xinhuanet.com. Retrieved 25 April 2021.
  111. "Tonga's Princess takes the lead on Covid-19 vaccination". RNZ. 16 April 2021. Retrieved 25 April 2021.
  112. "Kingdom of Tonga receives 24,000 doses of COVID-19 vaccines through the COVAX facility". World Health Organization (WHO). Retrieved 25 April 2021.
  113. AfricaNews (10 March 2021). "Uganda starts COVID-19 vaccinations". Africanews. Retrieved 19 March 2021.
  114. "COVID-19: AstraZeneca vaccine certified for use in Ukraine". covid.unian.info. Retrieved 10 March 2021.
  115. "Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Retrieved 4 January 2021.
  116. "Oxford University/AstraZeneca vaccine authorised by UK medicines regulator" (Press release). Department of Health and Social Care. 30 December 2020. Retrieved 30 December 2020.
  117. "Conditions of Authorisation for COVID-19 Vaccine AstraZeneca". Medicines and Healthcare products Regulatory Agency (MHRA). 30 December 2020. Retrieved 4 January 2021.
  118. "Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress". CNA. Retrieved 5 February 2021.
  119. "Yemen receives 360,000 COVID-19 vaccine doses through the COVAX Facility". www.unicef.org. Retrieved 7 June 2021.
  120. 1 2 "Zambia sets out plans to vaccinate all people over 18 against COVID-19". Reuters. 25 March 2021. Retrieved 17 April 2021.
  121. 1 2 "Zambia launches the COVID-19 vaccination". ReliefWeb. Retrieved 17 April 2021.
  122. 1 2 "Zambia gets 1st 228,000 vaccine doses from COVAX". aa.com.tr. Retrieved 17 April 2021.
  123. 1 2 3 4 "Marketing authorisation". European Medicines Agency (EMA). Retrieved 23 March 2021.
  124. 1 2 "CARPHA Issues its First Emergency Use Recommendation for a COVID-19 Vaccine". Caribbean Public Health Agency.
  125. "Suriname begins coronavirus vaccination campaign with donated doses". Reuters. 23 February 2021. Retrieved 28 February 2021.
  126. 1 2 3 Psyllides, George. "Coronavirus: 10,000 vaccines handed over to north". cyprus-mail.com/. Retrieved 17 April 2021.